KRAS as a Modulator of the Inflammatory Tumor Microenvironment: Therapeutic Implications.

Pereira, Flávia; Ferreira, Anabela; Reis, Celso Albuquerque; Sousa, Maria João; Oliveira, Maria José; Preto, Ana

Pereira, Flávia; Ferreira, Anabela; Reis, Celso Albuquerque; Sousa, Maria João; Oliveira, Maria José; Preto, Ana.

Afiliación

Pereira F; Centre of Molecular and Environmental Biology (CBMA), Department of Biology, Campus de Gualtar, University of Minho, 4710-057 Braga, Portugal.
Ferreira A; Institute of Science and Innovation for Bio-Sustainability (IB-S), Campus de Gualtar, University of Minho, 4710-057 Braga, Portugal.
Reis CA; Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal.
Sousa MJ; Institute of Biomedical Engineering (INEB), University of Porto, 4200-135 Porto, Portugal.
Oliveira MJ; Centre of Molecular and Environmental Biology (CBMA), Department of Biology, Campus de Gualtar, University of Minho, 4710-057 Braga, Portugal.
Preto A; Institute of Science and Innovation for Bio-Sustainability (IB-S), Campus de Gualtar, University of Minho, 4710-057 Braga, Portugal.

Cells ; 11(3)2022 01 24.

Article en En | MEDLINE | ID: mdl-35159208

Asunto(s)

Neoplasias Pulmonares; Proteínas Proto-Oncogénicas p21(ras); Humanos; Neoplasias Pulmonares/genética; Proteínas Proto-Oncogénicas p21(ras)/genética; Transducción de Señal; Microambiente Tumoral/genética

Palabras clave

KRAS mutations; colorectal cancer; inflammation; lung cancer; pancreatic cancer; therapy; tumor microenvironment

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Proto-Oncogénicas p21(ras) / Neoplasias Pulmonares Límite: Humans Idioma: En Revista: Cells Año: 2022 Tipo del documento: Article País de afiliación: Portugal Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google